期刊文献+

质子泵抑制剂、左氧氟沙星、阿莫西林方案对幽门螺杆菌根除的疗效观察 被引量:2

下载PDF
导出
摘要 目的评估PPI、左氧氟沙星、阿莫西林方案的疗效、安全性、耐受性。方法治疗组100例感染幽门螺杆菌(HP)的患者,采用根除方案为标准剂量的一种PPI、阿莫西林1.0 g bid、左氧氟沙星0.5 g qd,疗程10 d;对照组为100例HP感染者,采用根除方案为一种标准剂量的PPI、阿莫西林1.0 g bid,克拉霉素0.5g bid,疗程10 d。结果治疗组Hp的根除率为70.1%,对照组HP的根除率为72%,2组间HP的根除率差异无显著性。结论有PPI、左氧氟沙星、阿莫西林组成的三联疗法、安全性、耐受性较好,但其根除率低于80%,不建议其作为一线疗法。
作者 严菊香
出处 《淮海医药》 CAS 2011年第4期321-322,共2页 Journal of Huaihai Medicine
  • 相关文献

参考文献10

  • 1Mones J, Gisbert JP, Borda F,et al. Indications, diagnostic test and helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference[ J]. Rev Esp Enfern Dig,2005,97(5) :348-374.
  • 2Gisber JP, Calvet X, Gomollon F, et al. Grupo Conferencia Espanola de Consenso sobre helicobacter pylori. Tratamiento erradicador de helicohacter pylori, recommendations de laⅡConferenia Espanola de Consenso[ J]. Med Clin (Barc) ,2005,125(8) : 301-316.
  • 3Malfertheiner P, Megraud F, O' Morain C, et al. Current concepts in the management of Helicobacter pylori infection:the Maastricht Ill" Consensus Report[ J] ,Gut,2007,56(6) :772-781.
  • 4Malfertheiner P, Megraud F, O' Morain C, et al. Current European concepts in the management of Helicobacter pylori infection-the Maastricht Consensus Report. The European Helicobacter pylori Study Group(EHPSG) [ J]. Eur J Gastroenterol Hepatol, 1997,9 (1):1-2.
  • 5Gisbert JP,Gonzalez L,Calvet X,et al. Protom pump inhibitor, clar- ithromycin an either amoxicillin or nitrimidazole:a meta-analysis of eradication of Helicobacter pylori [ J ]. Aliment Pharmacol Ther, 2000,14(10) :1319-1328.
  • 6Graham DY, Lu H, Yamaoka. Therapy for Helicobacter pylori infec- tion can be improved : sequential therapy and beyond [ J ]. Drugs, 2008,68(6) :725-736.
  • 7Egan B J, Marzio L, O' Connor H, O' Morain C et al. Treatment of hellcobacter pylofi infection [ J ]. Helicobacter, 2008,13 ( supl. 1 ) : 35 -40.
  • 8Gisbert JP, De la Morena F. Systermatic review and meta-analyis: levofloxacinbased rescue regiimens after Helicobacter pylori treat- ment failure[ J]. Aliment Pharmacol Ther,2006,23 ( 1 ) :35-44.
  • 9Bogaerts P, Berthin C, Nizet H, et al. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains fi'om pa- tients living in Beligium[ J]. Helicobacter,2006,11 (5) :441 445.
  • 10Wu DC, Hsc PI, Wu jk, et al. Randomized controlled comparison of sequential and quadruple (concomitant) therapies for H. pylori infection[ J]. Gastroenterology,2008,134( supl. I) : 137.

同被引文献21

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部